Marengo Asia Hospitals Targets INR 5,000 Cr Valuation Through INR 500 Cr Stake Sale

It currently operates eight hospitals with nearly 2,500 beds across regions, including the National Capital Region, Gujarat, and Rajasthan, while establishing a footprint in Saudi Arabia.

Marengo Asia Hospitals, a network of multi-speciality hospitals in India, has initiated plans to secure INR 500 Cr by divesting a minority stake, valuing the company at approximately INR 5,000 Cr.

The move has been designed to bring in institutional investors and accelerate its expansion roadmap across domestic and international markets.

Founded with backing from Samara Capital, along with family offices linked to established Indian business groups, the hospital platform has steadily expanded since 2020 through an aggregation model.

It currently operates eight hospitals with nearly 2,500 beds across regions, including the National Capital Region, Gujarat, and Rajasthan, while also establishing a footprint in Saudi Arabia.

The hospital chain has reportedly shared its financial details with select investors, including sovereign wealth funds, pension funds, and healthcare-focused private equity players.

With reported revenues of around INR 1,200 Cr in FY25-26, the targeted INR 5,000 Cr valuation implies a price-to-sales multiple exceeding 4x, reflecting expectations of future scale.

India’s hospital sector has witnessed heightened investor activity in recent years, with private equity inflows exceeding INR 43,000 Cr between 2022 and 2024. Large listed hospital operators continue to trade at premium valuation multiples, supported by rising healthcare demand, insurance penetration, and increasing incidence of chronic diseases.

Marengo’s strategy also includes tapping into international opportunities, particularly in Saudi Arabia, where healthcare privatization efforts under Vision 2030 are driving demand for private sector participation.

Integration risks associated with rapid acquisitions, operational consistency across facilities, and regulatory uncertainties in both India and overseas markets remain key considerations.

Stay tuned for more such updates on Digital Health News